While it can be found as part of the normal microflora of the gastrointestinal tract, it can also cause severe diarrhoea in people who have recently taken antibiotics
in 44.8%, the onset-to-door time was 4.5 hours (median 5.5 hours [IQR 2.213.4]), and 25.2% of patients received any reperfusion therapy, IV thrombolysis in 23% (Figure 2)
Subcutaneous (SubQ) Injections A subcutaneous injection means injecting BPC-157 just under the skin , usually in the lower abdomen or thigh
[DOI] [PMC free article] [PubMed] [Google Scholar] Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D, et al
Can I split the daily oral BPC-157 dose
What the Research Says: Science Behind Peptide Therapy Recent studies on MOTS-c have shown promise in reversing age-related insulin resistance , while BPC-157 has been studied for its ability to improve healing and inflammation control , both of which are vital in the weight loss process